Quick Answer
Turn Therapeutics Inc. reported Stockholders Equity of $4.69 million for the year ending 2025.
- Turn Therapeutics Inc. showed an increase of +2,741.4% in Stockholders Equity from 2024 to 2025.
- This data is from Turn Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2024: -$414.3 thousand | Q3 2025: $504.0 thousand.
- Over the full 3 years of available data (2023 to 2025), Turn Therapeutics Inc.'s Stockholders Equity has grown by 5,364.4%.
- Historical annual values: Fiscal year 2025: $4.69 million | Fiscal year 2024: -$177.4 thousand | Fiscal year 2023: $85.8 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: